BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 29370485)

  • 1. Validity of the Maudsley Staging Method in Predicting Treatment-Resistant Depression Outcome Using the Netherlands Study of Depression and Anxiety.
    van Belkum SM; Geugies H; Lysen TS; Cleare AJ; Peeters FPML; Penninx BWJH; Schoevers RA; Ruhe HG
    J Clin Psychiatry; 2018; 79(1):. PubMed ID: 29370485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Dutch Measure for quantification of Treatment Resistance in Depression (DM-TRD): an extension of the Maudsley Staging Method.
    Peeters FP; Ruhe HG; Wichers M; Abidi L; Kaub K; van der Lande HJ; Spijker J; Huibers MJ; Schene AH
    J Affect Disord; 2016 Nov; 205():365-371. PubMed ID: 27568174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical staging of major depressive disorder: an empirical exploration.
    Verduijn J; Milaneschi Y; van Hemert AM; Schoevers RA; Hickie IB; Penninx BW; Beekman AT
    J Clin Psychiatry; 2015 Sep; 76(9):1200-8. PubMed ID: 26455670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validity of LIDAS (LIfetime Depression Assessment Self-report): a self-report online assessment of lifetime major depressive disorder.
    Bot M; Middeldorp CM; de Geus EJ; Lau HM; Sinke M; van Nieuwenhuizen B; Smit JH; Boomsma DI; Penninx BW
    Psychol Med; 2017 Jan; 47(2):279-289. PubMed ID: 27702414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting clinical course in major depressive disorder: The association between DM-TRD score and symptom severity over time in 1115 outpatients.
    van Dijk DA; van den Boogaard TM; Deen ML; Spijker J; Ruhé HG; Peeters FPML
    Depress Anxiety; 2019 Apr; 36(4):345-352. PubMed ID: 30474901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anxious distress predicts subsequent treatment outcome and side effects in depressed patients starting antidepressant treatment.
    Gaspersz R; Lamers F; Kent JM; Beekman ATF; Smit JH; van Hemert AM; Schoevers RA; Penninx BWJH
    J Psychiatr Res; 2017 Jan; 84():41-48. PubMed ID: 27693981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standardisation framework for the Maudsley staging method for treatment resistance in depression.
    Fekadu A; Donocik JG; Cleare AJ
    BMC Psychiatry; 2018 Apr; 18(1):100. PubMed ID: 29642877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The decision tool unipolar depression (DTUD): a new measure to facilitate the early identification of patients with major depressive disorder in need of highly specialized care.
    van Krugten FCW; Goorden M; van Balkom AJLM; van Oppen P; Ruhé HG; van Schaik DJF; Brouwer WBF; Hakkaart-van Roijen L;
    BMC Psychiatry; 2019 Jun; 19(1):179. PubMed ID: 31185975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Maudsley Staging Method for treatment-resistant depression: prediction of longer-term outcome and persistence of symptoms.
    Fekadu A; Wooderson SC; Markopoulou K; Cleare AJ
    J Clin Psychiatry; 2009 Jul; 70(7):952-7. PubMed ID: 19457299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid and Sustained Reductions in Current Suicidal Ideation Following Repeated Doses of Intravenous Ketamine: Secondary Analysis of an Open-Label Study.
    Ionescu DF; Swee MB; Pavone KJ; Taylor N; Akeju O; Baer L; Nyer M; Cassano P; Mischoulon D; Alpert JE; Brown EN; Nock MK; Fava M; Cusin C
    J Clin Psychiatry; 2016 Jun; 77(6):e719-25. PubMed ID: 27232360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors and Moderators of Remission With Aripiprazole Augmentation in Treatment-Resistant Late-Life Depression: An Analysis of the IRL-GRey Randomized Clinical Trial.
    Kaneriya SH; Robbins-Welty GA; Smagula SF; Karp JF; Butters MA; Lenze EJ; Mulsant BH; Blumberger D; Anderson SJ; Dew MA; Lotrich F; Aizenstein HJ; Diniz BS; Reynolds CF
    JAMA Psychiatry; 2016 Apr; 73(4):329-36. PubMed ID: 26963689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Maudsley Staging Method as predictor of electroconvulsive therapy effectiveness in depression.
    van Diermen L; Hebbrecht K; Schrijvers D; Sabbe BCG; Fransen E; Birkenhäger TK
    Acta Psychiatr Scand; 2018 Dec; 138(6):605-614. PubMed ID: 30270433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal relationships between happiness and psychiatric disorders and their symptom severity in a large cohort study: the Netherlands Study of Depression and Anxiety (NESDA).
    Spinhoven P; Elzinga BM; Penninx BWJH; Giltay EJ
    BMC Psychiatry; 2021 Jul; 21(1):344. PubMed ID: 34243747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dimensions of the inventory of depressive symptomatology as predictors of the course of depressive and anxiety disorders.
    Wardenaar KJ; Giltay EJ; van Veen T; Zitman FG; Penninx BW
    J Psychiatr Res; 2012 Dec; 46(12):1655-61. PubMed ID: 22995629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis of depressive disorders in the general population- results from the longitudinal Finnish Health 2011 Study.
    Markkula N; Härkänen T; Nieminen T; Peña S; Mattila AK; Koskinen S; Saarni SI; Suvisaari J
    J Affect Disord; 2016 Jan; 190():687-696. PubMed ID: 26600410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Difference in remission in a Chinese population with anxious versus nonanxious treatment-resistant depression: a report of OPERATION study.
    Wu Z; Chen J; Yuan C; Hong W; Peng D; Zhang C; Cao L; Fang Y
    J Affect Disord; 2013 Sep; 150(3):834-9. PubMed ID: 23570952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind, placebo-controlled, crossover trial evaluating the effect of intranasal insulin on cognition and mood in individuals with treatment-resistant major depressive disorder.
    Cha DS; Best MW; Bowie CR; Gallaugher LA; Woldeyohannes HO; Soczynska JK; Lewis G; MacQueen G; Sahakian BJ; Kennedy SH; Lui JP; Mansur RB; McIntyre RS
    J Affect Disord; 2017 Mar; 210():57-65. PubMed ID: 28013123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Depression Scale as a screening instrument for a subsequent depressive episode in primary healthcare patients.
    Poutanen O; Koivisto AM; Joukamaa M; Mattila A; Salokangas RK
    Br J Psychiatry; 2007 Jul; 191():50-4. PubMed ID: 17602125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is prior course of illness relevant to acute or longer-term outcomes in depressed out-patients? A STAR*D report.
    Rush AJ; Wisniewski SR; Zisook S; Fava M; Sung SC; Haley CL; Chan HN; Gilmer WS; Warden D; Nierenberg AA; Balasubramani GK; Gaynes BN; Trivedi MH; Hollon SD
    Psychol Med; 2012 Jun; 42(6):1131-49. PubMed ID: 22008447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relation between depressive and obsessive-compulsive symptoms in obsessive-compulsive disorder: Results from a large, naturalistic follow-up study.
    Rickelt J; Viechtbauer W; Lieverse R; Overbeek T; van Balkom AJ; van Oppen P; van den Heuvel OA; Marcelis M; Eikelenboom M; Tibi L; Schruers KR
    J Affect Disord; 2016 Oct; 203():241-247. PubMed ID: 27310102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.